Table 4. Multivariate analyses of factors associated with survival and recurrence.

	HR	95% CI	p
Overall survival
Lymph node metastasis	1.532	0.986–2.401	0.075
Satellite lesions	1.452	1.230–1.860	0.007
Tumor size	2.830	1.563–4.580	<0.001
Cancerous thrombi	1.848	1.429–2.543	<0.001
Cirrhosis nodules	2.791	0.940–3.540	0.042
High peritumoral co-expression of three factors	2.018	1.124–2.804	0.028
Time to recurrence
Lymph node metastasis	2.140	1.280–3.520	0.012
Satellite lesions	1.567	1.238–2.010	<0.001
Tumor size	1.329	1.122–1.598	0.008
Cancerous thrombi	1.411	1.130–1.745	0.003
High peritumoral co-expression of three factors	1.570	1.130–1.942	0.022

Abbreviations: HR, hazard ratio; CI, confidence interval.